Advent Life Sciences launches two funds totaling $215M, and teams with Harrington Discovery Institute to translate research
Longtime early-stage investor Advent Life Sciences has completed two new funds, and they’re ready to spend the cash.
Advent raised a combined $215 million between the two, announcing the raises early Thursday morning. The VC firm is calling them the Advent Life Sciences Fund III and the Advent-Harrington Impact Fund, the second of which is run jointly by the Harrington Discovery Institute, and is seeking roughly 15 to 18 new seed or Series A investments over the next four years or so.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.